Food & Beverage Online | B2B Food market platform in China
Product
  • Product
  • Buying Requests
  • Suppliers
Product
  • Product
  • Buying Requests
  • Suppliers
Food online >  Products >  Food Ingredients >  Functional Ingredients > 

Hydrolyzed Collagen Type II,China Semnl price supplier

Hydrolyzed Collagen Type II
FOB Price:Price can be negotiated
Update Time:2023-04-25
Product Description

 Introduction:

The articular cartilage is composed mainly of water (75%), collagen type II (15%) and aggrecans (9%) such as hyaluronic acid and chondroitin. Type II collagen is the predominant form of collagen in the sternal cartilage and accounts for approximately 60% of the dry weight of the cartilage. Dietary supplements that contain collagen type II, hyaluronic acid, and chondroitin sulfate may be beneficial during aging and treating joint diseases. 

SEMNL Collagen type II is extracted from the cartilage of chicken sternal cartilageand exhibits intriguing possibilities for the treatment of autoimmune diseases by inducing oral tolerance, which is composed of type II collagen peptide, hyaluronic acid, and chondroitin sulfate.

 

High quality material:

The quality of cartilage must meet the import standard of the EU and US, which may assure the safety of our peptide products.

 

Efficacy:

Eliminate the joint pain: Rheumatoid arthritis (RA) is an autoimmune, chronic inflammatory disorder affecting peripheral joints. According to experiments on human body, autoimmunity to an antigen such as cartilage peptide plays a major role in the pathogenesis of RA.

Stave osteoporosis;

Maintenance of healthy skin, hair and nails;

Other Products
Company Profile
Name: Beijing SEMNL Biotechnology Co., Ltd.
Main Products: Hydrolyzed Collagen type Ⅱ,Oyster peptide,elastin peptide Edible bird’s nest peptide,Soy Peptide,Jackfruit Peptide Walnut Peptide,Undenatured type II collagen
Total Employees: 50 ~ 100
Established Year: 2008
Main Markets: North America,South America,Eastern Europe,Southeast Asia,Africa,Oceania,Mid East,Eastern Asia,Western Europe,
Address: Room 1306-1307, building B, New World Center office building, 3 Chongwen Avenue, Dongcheng District,

The Leading Supplier of bioactive peptide in China

As a leading high-tech enterprise, Beijing SEMNL Biotechnology Co., Ltd. found in Beijing on 2006, mainly focuses on research, developing, producing and supply of hydrolyzed collagen products. Our hydrolyzed collagen type I products are derived from fish skin and scale, bovine skin/bone gelatin and hydrolyzed collagen type II are derived from chicken cartilage, which are widely used into health products, cosmetics and nutrition products by many market-leading companies worldwide.

SEMNL is known as one of the most qualified enterprises in China in the field of collagen production. Headquartered in Beijing, production based in Huaibei City, Anhui Province, Wu zhong City, Ningxia ProvinceWenchang City, Hainan Province and Chengmai Country, Hainan Province. SEMNL was officially identified as a high-tech enterprise by Chinese Government in 2009. Its production plant was established in accordance with GMP-standard; the annual output of hydrolyzed fish collagen is about 3,000 MT. SEMNL has established three sales and service centers separately in Beijing, Shanghai and Guangzhou, with a complete customer service management system and standard customer service processes.

more
Browse Hot Product By Alphabetically A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Beijing SEMNL Biotechnology Co., Ltd.
  • Main Products:Hydrolyzed Collagen type Ⅱ,Oyster peptide,elastin peptide Edible bird’s nest peptide,Soy Peptide,Jackfruit Peptide Walnut Peptide,Undenatured type II collagen
  • Main Markets: North America,South America,Eastern Europe,Southeast Asia,Africa,Oceania,Mid East,Eastern Asia,Western Europe,
  • Location: Beijing, Beijing, China
  • Year Established: 2008
Send your message
 
Contact Information
Contact: Ms.Wang hy
Tel: 86 - 010 - 87382160-813
Fax: - -
Chat Online
For
Buyers
For
Sellers
Share
Product
 
 
 
Share Product
Share to Facebook
Share to LinkedIn
Share to Twitter
Copy Link